Polymyositis complicating D-penicillamine treatment
- PMID: 1775410
- PMCID: PMC2399149
- DOI: 10.1136/pgmj.67.793.1018
Polymyositis complicating D-penicillamine treatment
Abstract
Although there is good evidence that D-penicillamine can induce polymyositis, the exact pathogenic mechanism remains unclear. We report two patients with psoriatic arthritis and primary biliary cirrhosis respectively, who developed polymyositis while receiving D-penicillamine treatment for their primary diseases. Whether D-penicillamine treatment was the sole cause of polymyositis or acted as a trigger for the development of a secondary autoimmune disease is discussed.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
